about
Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic ReviewMarine Diterpenoids as Potential Anti-Inflammatory AgentsTnfa signaling through tnfr2 protects skin against oxidative stress-induced inflammationStructural Basis for Treating Tumor Necrosis Factor (TNF )-associated Diseases with the Therapeutic Antibody InfliximabComparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular ViewEffects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic NephropathySingle domain antibodies: promising experimental and therapeutic tools in infection and immunityRegulation of tumour necrosis factor signalling: live or let dieThermodynamic additivity of sequence variations: an algorithm for creating high affinity peptides without large libraries or structural informationDiscovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α productionEtanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss.Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressureTumor Necrosis Factor-α-Induced Ototoxicity in Mouse Cochlear Organotypic Culture.Tumor necrosis factor-alpha-mutant mice exhibit high frequency hearing loss.The oxazolidinone derivative locostatin induces cytokine appeasement.A new family of synthetic diterpenes that regulates cytokine synthesis by inhibiting IkappaBalpha phosphorylation.In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopeniaPhosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling.Multiplexed Electrochemical Immunosensors for Clinical BiomarkersStructure-based repurposing of FDA-approved drugs as TNF-α inhibitors.Immunologic biomarkers for clinical and therapeutic management of psoriasis.iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPSSmall-molecule inhibitors of the interaction between TNF and TNFR.Melittin-glutathione S-transferase fusion protein exhibits anti-inflammatory properties and minimal toxicity.Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neuronsNeuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition.Anti-inflammatory function of arctiin by inhibiting COX-2 expression via NF-κB pathways.Akt fine-tunes NF-κB-dependent gene expression during T cell activationTargeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold.TNF superfamily protein-protein interactions: feasibility of small- molecule modulationA novel anti-TNF scFv constructed with human antibody frameworks and antagonistic peptides.Suppressive effects of Mimosa pudica (L.) constituents on the production of LPS-induced pro-inflammatory mediatorsMalignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.mRNA transcript diversity creates new opportunities for pharmacological intervention.Within-Host Models of High and Low Pathogenic Influenza Virus Infections: The Role of MacrophagesTrial Watch: Immunostimulatory cytokines.Ageing and metabolism: drug discovery opportunities.Chemical composition, phytochemical constituents, antioxidant and anti-inflammatory activities of Urtica urens L. leaves.Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm
P2860
Q26749017-BB5C07A8-1A24-4B67-A19E-07E804A6EABAQ26779952-BD8C43DA-44E3-4BE6-8686-354FCA96D3D1Q27314999-3216A546-94B7-43C9-9BFC-3C3636F4D8DDQ27676857-17693FCD-102E-4BF9-AA1C-981319BA4BB3Q27679553-15E10AAA-8464-4563-B2AE-7751741132C4Q28080888-D5B81E1E-B9C7-42BE-BAB1-0F193435A129Q28248678-5783C3E5-6EB6-4604-A564-A7018CFE1952Q28262381-93CC959A-61DE-47CB-975C-D4E1753E19DDQ28476115-25390B48-4CA8-4B14-9547-154011B2D6ECQ28484258-C8ABB656-1B3D-4BAB-89BA-0CDBF9D30F97Q30009390-7D4BB494-34E8-450C-94EE-8381EB448631Q30358256-B8868877-6FB3-4D3E-96BD-034219ED8DD9Q30410865-FC45A163-D9C0-4636-B367-EA187C2BA34CQ30424146-F80FA2B6-44B0-49B3-B47C-D8FFADBE6863Q30887007-2199A7B1-38EA-424F-AA7F-840020202840Q30975970-79234A89-2981-4C96-B658-3E62D9C3C632Q33417826-6057D3B0-3509-48D4-B8BA-2535EE9A251BQ33704501-EA1B5A55-8DE9-4484-803E-94210E3368A0Q33777764-2C9A0DD4-5D14-410E-8481-9AABEC846AB2Q33834499-9404537F-EF71-4BF1-B332-8CBE5BDEF140Q34030644-87F9AB9A-F25F-41C5-AB34-50C171A6335AQ34247201-3CB2E6C3-EA9C-48DF-B83D-25A72FCDB477Q34519187-2776E0F2-CD8C-4C75-95E8-0728182E11A2Q34620675-8C43DC73-18BB-4220-B622-6375BAD88A0BQ34708824-229446F2-6F72-4840-BEB1-A8B90DD1B003Q35116500-A0A40D95-3C7D-4F70-AB2D-609DC65A8591Q35137226-F53C6199-C4C5-4E80-873B-9F0D654FB5F1Q35371427-CB9AB27A-CD9F-4462-8CCC-755FAE9F1DCCQ35484964-B5ADD8B4-C842-42F1-A459-FCE3625B1B84Q35534271-208DD936-A0FE-4F4E-9C5B-1D6C38DC4CDDQ35658998-66E6210D-D10B-4E42-99F9-CB646A71969FQ35726973-CC109983-6A04-4E4A-8D4A-5B70016BEB64Q35842876-712CD656-7574-41AF-AFF8-F56414407CACQ35911103-155933CE-026E-42BA-8077-B2127AFEA4D0Q35913120-8A432224-D8D2-4848-A0FD-8417A520BCAEQ35936916-4BB4A260-A270-40DE-8B72-2BAA3E3453F6Q36057492-C6542A2D-A1C2-4FC0-81FA-2F52C541ABAFQ36174012-7868666C-8C4F-4755-B6B9-8B45BC0905FAQ36222537-116FA35B-5C1C-4512-A192-4B4E2F07BABFQ36248775-08C0F760-51F3-4470-8406-B7A09C58D53A
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Anti-TNF-alpha therapies: the next generation.
@ast
Anti-TNF-alpha therapies: the next generation.
@en
Anti-TNF-alpha therapies: the next generation.
@nl
type
label
Anti-TNF-alpha therapies: the next generation.
@ast
Anti-TNF-alpha therapies: the next generation.
@en
Anti-TNF-alpha therapies: the next generation.
@nl
prefLabel
Anti-TNF-alpha therapies: the next generation.
@ast
Anti-TNF-alpha therapies: the next generation.
@en
Anti-TNF-alpha therapies: the next generation.
@nl
P2093
P356
P1476
Anti-TNF-alpha therapies: the next generation.
@en
P2093
Emmanuel A Theodorakis
Frances Rena Bahjat
Lyle L Moldawer
Michael A Palladino
P2888
P304
P356
10.1038/NRD1175
P577
2003-09-01T00:00:00Z